XML 65 R11.htm IDEA: XBRL DOCUMENT
v3.20.1

Segment Information | 12 Months Ended
--- | ---
Dec. 31, 2019
Segment Reporting [Abstract] |
Segment Information | Management has concluded that Life Sciences, Mobile Solutions, and Power Solutions constitute our operating segments. Life Sciences, Mobile Solutions, and Power Solutions are considered operating segments as each engages in business activities for which it earns revenues and incurs expenses, discrete financial information is available for each, and this is the level at which the Chief Operating Decision Maker (“CODM”) reviews discrete financial information for purposes of allocating resources and assessing performance. Life Sciences Life Sciences is focused on growth in the medical end market, primarily in the orthopaedics and medical/surgical end markets. Within this group we combine advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices. We manufacture a variety of components, assemblies, and instruments, such as surgical knives, bioresorbable implants, surgical staples, cases and trays, orthopaedic implants and tools, laparoscopic devices, and drug delivery devices for the orthopaedics and medical/surgical end markets. Mobile Solutions Mobile Solutions is focused on growth in the general industrial and automotive end markets. We have developed an expertise in manufacturing highly complex, system critical components for fuel systems, engines and transmissions, power steering systems, and electromechanical motors on a high-volume basis. This expertise has been gained through investment in technical capabilities, processes and systems, and skilled program management and product launch capabilities. Power Solutions Power Solutions is focused on growth in the electrical and aerospace and defense end markets. Within this group we combine materials science expertise with advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components, assemblies, and finished devices used in applications ranging from power control to flight control and for military devices. We manufacture a variety of products including electrical contacts, connectors, contact assemblies, and precision stampings for the electrical end market and high precision products for the aerospace and defense end markets utilizing our extensive process technologies for optical grade plastics, thermally conductive plastics, titanium, Inconel, magnesium, and electroplating. Segment Results The following tables present certain operations information by reportable segment.
|  | Life Sciences |  | Mobile Solutions |  | Power Solutions |  | Corporate and Consolidations |  | Total
Year Ended December 31, 2019 |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 359,732 |  |  | $ | 297,749 |  |  | $ | 192,100 |  |  | $ | (2,130 | ) | (a) | $ | 847,451 |
Depreciation and amortization |  | 46,905 |  |  | 27,146 |  |  | 15,301 |  |  | 2,494 |  |  | 91,846 |
Income (loss) from operations |  | 28,157 |  |  | 9,553 |  |  | 13,881 |  |  | (41,702 | ) |  | $ | 9,889 |
Interest expense |  |  |  |  |  |  |  |  |  | (57,155 | )
Other |  |  |  |  |  |  |  |  |  | (4,433 | )
Loss before provision for income taxes and share of net income from joint venture |  |  |  |  |  |  |  |  |  | $ | (51,699 | )
Share of net income from joint venture |  | $ | — |  |  | $ | 1,681 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,681 |
Expenditures for long-lived assets |  | 21,445 |  |  | 24,969 |  |  | 4,457 |  |  | 3,132 |  |  | 54,003 |
Total assets |  | 811,526 |  |  | 373,256 |  |  | 310,545 |  |  | 46,657 |  | (b) | 1,541,984 |
|  | Life Sciences |  | Mobile Solutions |  | Power Solutions |  | Corporate and Consolidations |  | Total
Year Ended December 31, 2018 |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 248,173 |  |  | $ | 335,037 |  |  | $ | 189,778 |  |  | $ | (2,331 | ) | (a) | $ | 770,657 |
Depreciation and amortization |  | 28,091 |  |  | 26,217 |  |  | 14,753 |  |  | 2,067 |  |  | 71,128 |
Goodwill impairment |  | — |  |  | 73,442 |  |  | 109,100 |  |  | — |  |  | 182,542 |
Income (loss) from operations |  | 19,136 |  |  | (55,079 | ) |  | (95,115 | ) |  | (48,806 | ) |  | $ | (179,864 | )
Interest expense |  |  |  |  |  |  |  |  |  | (61,243 | )
Other |  |  |  |  |  |  |  |  |  | (20,903 | )
Loss before benefit for income taxes and share of net income from joint venture |  |  |  |  |  |  |  |  |  | $ | (262,010 | )
Share of net income from joint venture |  | $ | — |  |  | $ | (14,390 | ) |  | $ | — |  |  | $ | — |  |  | $ | (14,390 | )
Expenditures for long-lived assets |  | 14,645 |  |  | 36,660 |  |  | 6,459 |  |  | 6,272 |  |  | 64,036 |
Total assets |  | 802,770 |  |  | 354,542 |  |  | 297,947 |  |  | 45,643 |  | (b) | 1,500,902 |
|  | Life Sciences |  | Mobile Solutions |  | Power Solutions |  | Corporate and Consolidations |  | Total
Year Ended December 31, 2017 |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 98,329 |  |  | $ | 336,852 |  |  | $ | 186,602 |  |  | $ | (1,990 | ) | (a) | $ | 619,793 |
Depreciation and amortization |  | 12,088 |  |  | 24,491 |  |  | 14,657 |  |  | 1,170 |  |  | 52,406 |
Income (loss) from operations |  | 13,271 |  |  | 33,071 |  |  | 23,440 |  |  | (38,002 | ) |  | $ | 31,780 |
Interest expense |  |  |  |  |  |  |  |  |  | (52,085 | )
Other |  |  |  |  |  |  |  |  |  | (39,902 | )
Loss before benefit for income taxes and share of net income from joint venture |  |  |  |  |  |  |  |  |  | $ | (60,207 | )
Share of net income from joint venture |  | $ | — |  |  | $ | 5,211 |  |  | $ | — |  |  | $ | — |  |  | $ | 5,211 |
Expenditures for long-lived assets |  | — |  |  | 24,056 |  |  | 5,443 |  |  | 6,907 |  |  | 36,406 |
Total assets |  | 353,208 |  |  | 427,027 |  |  | 385,558 |  |  | 307,916 |  |  | 1,473,709 |
_______________________________ (a) Includes eliminations of intersegment transactions which occur during the ordinary course of business. (b) Total assets in Mobile Solutions includes $21.8 million and $20.4 million as of December 31, 2019 and 2018, respectively, related to the investment in our 49% owned joint venture (Note 11). The following table summarizes the net sales and income (loss) from operations from acquisitions in the Life Sciences and Power Solutions groups for the years ended December 31, 2018 and 2017.
|  | Year Ended December 31,
|  | 2018 |  | 2017
Net sales |  |  |  |
Paragon Medical |  | $ | 116,998 |  |  | $ | — |
Other |  | 42,636 |  |  | 6,682 |
Income (loss) from operations |  |  |  |
Paragon Medical |  | $ | 8,086 |  |  | $ | — |
Other |  | 1,816 |  |  | (458 | )
The following table summarizes long-lived tangible assets by geographical region.
|  | Property, Plant, and Equipment, Net As of December 31,
|  | 2019 |  | 2018
United States |  | $ | 250,163 |  |  | $ | 235,975 |
Europe |  | 54,829 |  |  | 50,143 |
Asia |  | 43,128 |  |  | 42,657 |
Mexico |  | 1,388 |  |  | 7,647 |
S. America |  | 25,005 |  |  | 24,606 |
All foreign countries |  | $ | 124,350 |  |  | $ | 125,053 |
Total |  | $ | 374,513 |  |  | $ | 361,028 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration